Showing 161-170 of 187 results for "".
Is Biopsy Effective for BCC on the Head and Neck?; Ask an Expert: Wound Care and Healing
https://practicaldermatology.com/youngmd-connect/resident-resource-center/is-biopsy-effective-for-bcc-on-the-head-and-neck-ask-an-expert-wound-care-and-healing/21141/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20614/Indoor Tanning Beds: The Dangers of Adolescent Tanning
https://practicaldermatology.com/topics/skin-cancer-photoprotection/indoor-tanning-beds-the-dangers-of-adolescent-tanning/22973/As research continues to shed light on the connection between UV exposure and skin cancer, greater efforts are required to inform the public and affect the legislative process.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21709/Therapeutics Update: Notable Approvals in 2017
https://practicaldermatology.com/topics/skin-cancer-photoprotection/therapeutics-update-notable-approvals-in-2017/20398/A look at the newest additions to the medicine chest.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-38/23774/2019 In Review
https://practicaldermatology.com/topics/practice-management/2019-in-review/23168/A look back at approvals, data, and industry developments of the year.- Miriam Bettencourt, MD, FAADhttps://practicaldermatology.com/profiles/miriam-bettencourt-md-faad/LbxP4z/Miriam S. Bettencourt, MD, is a board-certified Fellow of the American Academy of Dermatology, a clinical professor of dermatology at the University of Nevada, and an adjunct professor at Touro University. She practices medical and cosmetic dermatology and Mohs surgery at Thomas Dermatology’s Hende…
- Emil Tanghetti, MDhttps://practicaldermatology.com/profiles/emil-tanghetti-md/7N5rqk/He attended U.C Davis where he excelled in his studies and received early admission to UCLA School of Medicine after only three years of undergraduate studies. Upon completing his medical studies and a 1-year pathology fellowship Dr. Tanghetti graduated first in his class and received the Dean Warr…
- ACLARIS files NDA For Novel Seborrheic Keratosis Treatmenthttps://practicaldermatology.com/news/aclaris-files-nda-for-novel-seborrheic-keratosis-treatment/2458272/Aclaris Therapeutics, Inc. submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for A-101 40% topical solution (A-101) as a treatment for seborrheic keratosis (SK). If approved, A-101 would be the first FDA-approved t